Literature DB >> 22683238

The human gut microbiome: current knowledge, challenges, and future directions.

Maneesh Dave1, Peter D Higgins, Sumit Middha, Kevin P Rioux.   

Abstract

The Human Genome Project was completed a decade ago, leaving a legacy of process, tools, and infrastructure now being turned to the study of the microbes that reside in and on the human body as determinants of health and disease, and has been branded "The Human Microbiome Project." Of the various niches under investigation, the human gut houses the most complex and abundant microbial community and is an arena for important host-microbial interactions that have both local and systemic impact. Initial studies of the human microbiome have been largely descriptive, a testing ground for innovative molecular techniques and new hypotheses. Methods for studying the microbiome have quickly evolved from low-resolution surveys of microbial community structure to high-definition description of composition, function, and ecology. Next-generation sequencing technologies combined with advanced bioinformatics place us at the doorstep of revolutionary insight into the composition, capability, and activity of the human intestinal microbiome. Renewed efforts to cultivate previously "uncultivable" microbes will be important to the overall understanding of gut ecology. There remain numerous methodological challenges to the effective study and understanding of the gut microbiome, largely relating to study design, sample collection, and the number of predictor variables. Strategic collaboration of clinicians, microbiologists, molecular biologists, computational scientists, and bioinformaticians is the ideal paradigm for success in this field. Meaningful interpretation of the gut microbiome requires that host genetic and environmental influences be controlled or accounted for. Understanding the gut microbiome in healthy humans is a foundation for discovering its influence in various important gastrointestinal and nutritional diseases (eg, inflammatory bowel disease, diabetes, and obesity), and for rational translation to human health gains.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22683238     DOI: 10.1016/j.trsl.2012.05.003

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  93 in total

1.  Gut microbiome compositional and functional differences between tumor and non-tumor adjacent tissues from cohorts from the US and Spain.

Authors:  Imane Allali; Susana Delgado; Pablo Isidro Marron; Aurora Astudillo; Jen Jen Yeh; Hassan Ghazal; Saaïd Amzazi; Temitope Keku; M Andrea Azcarate-Peril
Journal:  Gut Microbes       Date:  2015

2.  Acquisition of oral microbes and associated systemic responses of newborn nonhuman primates.

Authors:  J L Ebersole; S C Holt; J E Delaney
Journal:  Clin Vaccine Immunol       Date:  2013-10-30

3.  [Motility disorders of the gastrointestinal tract].

Authors:  J Mössner
Journal:  Internist (Berl)       Date:  2015-06       Impact factor: 0.743

Review 4.  Microbial source tracking using metagenomics and other new technologies.

Authors:  Shahbaz Raza; Jungman Kim; Michael J Sadowsky; Tatsuya Unno
Journal:  J Microbiol       Date:  2021-02-10       Impact factor: 3.422

5.  [A preliminary analysis of changes in composition of intestinal microbiota during infancy using polymerase chain reaction-denaturing gradient gel electrophoresis].

Authors:  Shan-Shan Li; Jun-Jie Miao; Zi-Xi Wu; Jian-Rong Yao; Ming Li; Qian Yu; Fang He
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2017-03

Review 6.  Antibiotics, gut microbiota, environment in early life and type 1 diabetes.

Authors:  Youjia Hu; F Susan Wong; Li Wen
Journal:  Pharmacol Res       Date:  2017-02-07       Impact factor: 7.658

Review 7.  Immunology of inflammatory bowel disease and molecular targets for biologics.

Authors:  Maneesh Dave; Konstantinos A Papadakis; William A Faubion
Journal:  Gastroenterol Clin North Am       Date:  2014-09       Impact factor: 3.806

Review 8.  The microbiome in inflammatory bowel disease: current status and the future ahead.

Authors:  Aleksandar D Kostic; Ramnik J Xavier; Dirk Gevers
Journal:  Gastroenterology       Date:  2014-02-19       Impact factor: 22.682

Review 9.  The intestinal microbiome in type 1 diabetes.

Authors:  J L Dunne; E W Triplett; D Gevers; R Xavier; R Insel; J Danska; M A Atkinson
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

Review 10.  Influence of host immunoregulatory genes, ER stress and gut microbiota on the shared pathogenesis of inflammatory bowel disease and Type 1 diabetes.

Authors:  Altin Gjymishka; Roxana M Coman; Todd M Brusko; Sarah C Glover
Journal:  Immunotherapy       Date:  2013-12       Impact factor: 4.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.